Bolt Biotherapeutics, Inc. - BOLT
Sector:
Healthcare
· Industry:
Pharmaceutical Preparations
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q3 2026
· Q2 2026
Value (USD)
Total reported value ($000)
$2.292M
QoQ value delta ($000)
-$7K
(-0.3%)
Implied price effect (QoQ)
-0.28%
Shares
Total shares
596,407
QoQ shares delta
-120
(-0.02%)
Total shares held by funds (by quarter)
Shares (left)
Fund holders (right)
Market chart (BOLT)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q3 2026)
Top 25 only
Full list
Partial Q3 2026 data: 2 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| Sofinnova Investments, Inc. | 530 | 137,721 | 0.03% |
| RENAISSANCE TECHNOLOGIES LLC | 379 | 98,625 | 0.0% |
| Vivo Capital, LLC | 278 | 72,414 | 0.03% |
| CITADEL ADVISORS LLC | 219 | 56,903 | 0.0% |
| T3 Companies, LLC | 139 | 38,000 | 0.13% |
| Board of Trustees of The Leland Stanford Junior University | 138 | 35,977 | 0.03% |
| PFIZER INC | 133 | 31,305 | 0.08% |
| Lynx1 Capital Management LP | 118 | 30,800 | 0.01% |
| NANO CAP NEW MILLENNIUM GROWTH FUND L P | 105 | 27,500 | 0.08% |
| GEODE CAPITAL MANAGEMENT, LLC | 73 | 19,119 | 0.0% |
| Shay Capital LLC | 59 | 15,438 | 0.0% |
| BlackRock, Inc. | 37 | 9,711 | 0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 27 | 7,060 | 0.0% |
| Nan Fung Group Holdings Ltd | 19 | 5,000 | 0.01% |
| MORGAN STANLEY | 12 | 3,145 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 11 | 3,095 | 0.0% |
| NewEdge Advisors, LLC | 9 | 2,530 | 0.0% |
| Tower Research Capital LLC (TRC) | 6 | 1,710 | 0.0% |
| JPMORGAN CHASE & CO | 0 | 42 | 0.0% |
| BARCLAYS PLC | 0 | 6 | 0.0% |
| CITIGROUP INC | 0 | 41 | 0.0% |
| UBS Group AG | 0 | 255 | 0.0% |
| SBI Securities Co., Ltd. | 0 | 10 | 0.0% |